Skip to Content

Lannett Company, Inc. (NYSE: LCI)

Securities Class Action

Overview
  • Date:
  • 5/16/2019
  • Company Name:
  • Lannet Company, Inc.
  • Stock Symbol:
  • LCI
  • Status:
  • Filed

Case Finder

Locate any case using the tools below.

NEW YORK, May 16, 2019 – Bragar Eagel & Squire, P.C. is investigating potential claims against Lannett Company, Inc. (NYSE: LCI) on behalf of Lannett stockholders.  Our investigation concerns whether Lannett has violated the federal securities laws and/or engaged in other unlawful business practices.

On May 7, 2019, Lannett filed a Form 10-Q stating that on May 1, 2019, the company and one of its employees received written notice from various state Attorneys General that they intend to bring claims alleging price fixing and anti-competitive behavior with respect to certain drug products, some of which are manufactured and distributed by the company.

On this news, Lannett’s stock price fell by more than 15%, closing at $7.19 on May 8, 2019.

If you purchased or otherwise acquired Lannett shares, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Melissa Fortunato by email at investigations@bespc.com, or telephone at (212) 355-4648, or by filling out the contact form below. There is no cost or obligation to you.

Case Finder

Locate any case using the tools below.

You may share a link to this page on any of the sites listed below or send link via email: